m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma

Figure 7

Abnormally activated signaling pathways in the two subgroups after Gene Set Enrichment Analysis. (a–d) Performed in the high-risk group, including unfolded protein response (ES = 0.42, , FDR = 0.110), DNA repair signaling pathway (ES = 0.41, , FDR = 0.070), epithelial-mesenchymal transition signaling pathway (ES = 0.55, , FDR = 0.337), and glycolysis pathway (ES = 0.44, , FDR = 0.087). (e–f) Performed in the low-risk group, including estrogen response early (ES = 0.40, , FDR = 1.0) and KRAS signaling pathway (ES = 0.40, , FDR = 1.0).

(a)

(b)

(c)

(d)

(e)

(f)